Treatment Sequencing in LBCL: Clinical Trial and Real-World Data

Experts discuss the role of clinical and real-world data in informing treatment sequencing in patients with large B-cell lymphoma (LBCL) in the academic and community setting.

Video Player is loading.

Play Video

Play

Mute

Current Time 0:00

/

Duration 0:00

Loaded: 0%

0:00

Stream Type LIVE

Seek to live, currently behind liveLIVE

Remaining Time -0:00

 

1x

Playback Rate

Chapters

• Chapters

Descriptions

• descriptions off, selected

Captions

• captions settings, opens captions settings dialog
• captions off, selected

Audio Track

Fullscreen

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

Text

ColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-Transparent

Background

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparent

Window

ColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque

Font Size

50%75%100%125%150%175%200%300%400%

Text Edge Style

NoneRaisedDepressedUniformDropshadow

Font Family

Proportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps

Reset restore all settings to the default valuesDone

Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

EP: 1.Overview of Large B-Cell Lymphoma (LBCL)

EP: 2.CAR T-Cell Therapy in R/R LBCL: TRANSFORM, ZUMA-7, and PILOT Studies

EP: 3.Treatment Strategies for Patients with R/R LBCL

EP: 4.CAR T-Cell Therapy as Second-Line Treatment in LBCL

EP: 5.Choosing the Appropriate CAR T-Cell Therapy in Patients with R/R DLBCL

EP: 6.Additional Key Data Updates from ASH 2022 on Treatment of LBCL

Now Viewing

EP: 7.Treatment Sequencing in LBCL: Clinical Trial and Real-World Data

EP: 8.Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL

Recent Videos

Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL

Additional Key Data Updates from ASH 2022 on Treatment of LBCL

Choosing the Appropriate CAR T-Cell Therapy in Patients with R/R DLBCL

CAR T-Cell Therapy as Second-Line Treatment in LBCL

CAR T-Cell Therapy in R/R LBCL: TRANSFORM, ZUMA-7, and PILOT Studies

Treatment Strategies for Patients with R/R LBCL

Overview of Large B-Cell Lymphoma (LBCL)